Numeric Investors Cut Its Bristow Group (BRS) Position by $501,800; Oak Ridge Investments Stake In Supernus Pharmaceuticals (SUPN) Was Upped

May 18, 2018 - By Hazel Jackson

Bristow Group Inc. (NYSE:BRS) Logo

Numeric Investors Llc decreased its stake in Bristow Group Inc (BRS) by 51.26% based on its latest 2017Q4 regulatory filing with the SEC. Numeric Investors Llc sold 38,600 shares as the company’s stock declined 4.45% with the market. The institutional investor held 36,700 shares of the transportation services company at the end of 2017Q4, valued at $494,000, down from 75,300 at the end of the previous reported quarter. Numeric Investors Llc who had been investing in Bristow Group Inc for a number of months, seems to be less bullish one the $661.55 million market cap company. The stock decreased 0.11% or $0.02 during the last trading session, reaching $18.7. About 49,599 shares traded. Bristow Group Inc. (NYSE:BRS) has risen 0.31% since May 18, 2017 and is uptrending. It has underperformed by 11.24% the S&P500.




Oak Ridge Investments Llc increased its stake in Supernus Pharmaceuticals Inc (SUPN) by 49.32% based on its latest 2017Q4 regulatory filing with the SEC. Oak Ridge Investments Llc bought 86,104 shares as the company’s stock rose 16.22% while stock markets declined. The institutional investor held 260,676 shares of the health care company at the end of 2017Q4, valued at $10.39 million, up from 174,572 at the end of the previous reported quarter. Oak Ridge Investments Llc who had been investing in Supernus Pharmaceuticals Inc for a number of months, seems to be bullish on the $2.90B market cap company. The stock decreased 0.88% or $0.5 during the last trading session, reaching $56. About 309,396 shares traded. Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has risen 46.59% since May 18, 2017 and is uptrending. It has outperformed by 35.04% the S&P500.

Since January 2, 2018, it had 0 buys, and 11 selling transactions for $15.85 million activity. Another trade for 7,868 shares valued at $455,759 was made by Bhatt Padmanabh P. on Tuesday, May 15. The insider PATRICK GREGORY S sold 50,000 shares worth $2.18M.

Oak Ridge Investments Llc, which manages about $4.04 billion and $2.10 billion US Long portfolio, decreased its stake in Ollies Bargain Outlt Hldgs Inc by 253,264 shares to 659,327 shares, valued at $35.11M in 2017Q4, according to the filing. It also reduced its holding in Danaher Corp Del Com (NYSE:DHR) by 5,361 shares in the quarter, leaving it with 127,093 shares, and cut its stake in Eog Res Inc Com (NYSE:EOG).

Another recent and important Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) news was published by Seekingalpha.com which published an article titled: “Supernus Pharmaceuticals’ (SUPN) CEO, Jack Khattar on Q1 2018 Results – Earnings Call Transcript” on May 09, 2018.

Investors sentiment increased to 1.1 in Q4 2017. Its up 0.12, from 0.98 in 2017Q3. It improved, as 22 investors sold SUPN shares while 93 reduced holdings. 43 funds opened positions while 83 raised stakes. 47.19 million shares or 3.19% less from 48.75 million shares in 2017Q3 were reported. United Svcs Automobile Association invested 0.01% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). United Kingdom-based Barclays Pcl has invested 0% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Grp One Trading Lp invested 0% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Thrivent For Lutherans reported 0% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Jpmorgan Chase has 0% invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) for 173,527 shares. Arizona State Retirement Sys stated it has 86,161 shares. Invesco holds 0.02% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) for 1.59 million shares. Geode Cap Management Ltd Co holds 0.01% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) for 464,740 shares. Advisory Ser Network Limited Liability Company accumulated 119 shares. Teachers Retirement Sys Of The State Of Kentucky, a Kentucky-based fund reported 17,000 shares. Public Sector Pension Board reported 48,516 shares. Dekabank Deutsche Girozentrale stated it has 0.01% of its portfolio in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Parkside Savings Bank Tru holds 0% or 31 shares in its portfolio. Farmers Merchants Invs holds 0% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) or 239 shares. First Interstate Bancshares, a Montana-based fund reported 400 shares.

Among 11 analysts covering Supernus Pharmaceuticals (NASDAQ:SUPN), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Supernus Pharmaceuticals had 39 analyst reports since August 26, 2015 according to SRatingsIntel. The stock has “Buy” rating by Janney Capital on Monday, December 4. The stock has “Hold” rating by Zacks on Wednesday, August 26. Piper Jaffray maintained the shares of SUPN in report on Wednesday, February 28 with “Hold” rating. The company was maintained on Thursday, August 3 by Jefferies. Stifel Nicolaus maintained Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) rating on Tuesday, January 2. Stifel Nicolaus has “Buy” rating and $48.0 target. FBR Capital maintained it with “Buy” rating and $50.0 target in Monday, November 20 report. Stifel Nicolaus downgraded Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) on Tuesday, September 19 to “Hold” rating. The firm has “Buy” rating given on Wednesday, July 5 by Cantor Fitzgerald. The stock of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has “Buy” rating given on Wednesday, February 28 by Cantor Fitzgerald. Northland Capital downgraded the stock to “Market Perform” rating in Monday, July 18 report.

Another recent and important Bristow Group Inc. (NYSE:BRS) news was published by Prnewswire.com which published an article titled: “Bristow Group Announces Fiscal Year 2018 Fourth Quarter Earnings Release and Conference Call Schedule” on May 10, 2018.

Investors sentiment decreased to 0.78 in Q4 2017. Its down 0.55, from 1.33 in 2017Q3. It is negative, as 18 investors sold BRS shares while 51 reduced holdings. 22 funds opened positions while 32 raised stakes. 36.99 million shares or 4.81% less from 38.86 million shares in 2017Q3 were reported. Carmignac Gestion invested in 1.05M shares or 0.09% of the stock. Geode Capital Mgmt Limited Liability Company holds 0% of its portfolio in Bristow Group Inc. (NYSE:BRS) for 264,583 shares. Millennium Ltd reported 0% of its portfolio in Bristow Group Inc. (NYSE:BRS). Jpmorgan Chase stated it has 0% of its portfolio in Bristow Group Inc. (NYSE:BRS). The Illinois-based Wolverine Asset Ltd Limited Liability Company has invested 0.02% in Bristow Group Inc. (NYSE:BRS). Texas Permanent School Fund invested 0% in Bristow Group Inc. (NYSE:BRS). Bank Of Montreal Can holds 2,600 shares. Denver Investment Advisors Limited Liability Company has invested 0.01% in Bristow Group Inc. (NYSE:BRS). The Massachusetts-based State Street has invested 0% in Bristow Group Inc. (NYSE:BRS). Ing Groep Nv stated it has 100,000 shares or 0.02% of all its holdings. Wells Fargo And Mn reported 136,952 shares. Mason Street Advsrs Ltd Liability reported 0% of its portfolio in Bristow Group Inc. (NYSE:BRS). Goldman Sachs Gru stated it has 0% of its portfolio in Bristow Group Inc. (NYSE:BRS). New York State Common Retirement Fund reported 32,100 shares stake. 186 were reported by Us Savings Bank De.

Numeric Investors Llc, which manages about $14.26B and $13.74B US Long portfolio, upped its stake in Cisco Sys Inc (NASDAQ:CSCO) by 19,300 shares to 136,900 shares, valued at $5.24M in 2017Q4, according to the filing. It also increased its holding in Duke Energy Corp New (NYSE:DUK) by 27,300 shares in the quarter, for a total of 49,900 shares, and has risen its stake in Kirklands Inc (NASDAQ:KIRK).

Among 8 analysts covering Bristow Group (NYSE:BRS), 1 have Buy rating, 0 Sell and 7 Hold. Therefore 13% are positive. Bristow Group had 30 analyst reports since August 7, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of BRS in report on Wednesday, August 30 with “Hold” rating. The stock of Bristow Group Inc. (NYSE:BRS) has “Neutral” rating given on Monday, February 12 by Credit Suisse. Barclays Capital upgraded Bristow Group Inc. (NYSE:BRS) rating on Monday, June 6. Barclays Capital has “Overweight” rating and $20 target. The stock of Bristow Group Inc. (NYSE:BRS) has “Outperform” rating given on Thursday, September 1 by Cowen & Co. The company was maintained on Thursday, October 1 by Oppenheimer. On Tuesday, November 14 the stock rating was maintained by Barclays Capital with “Equal-Weight”. The firm has “Outperform” rating given on Tuesday, February 16 by Cowen & Co. The company was maintained on Tuesday, February 7 by Barclays Capital. The stock has “Neutral” rating by Credit Suisse on Tuesday, February 9. The rating was maintained by Credit Suisse on Friday, August 7 with “Neutral”.

Bristow Group Inc. (NYSE:BRS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.